[Treatment of experimental trypanosomiasis of sheep caused by Trypanosoma brucei brucei: efficacy of Ro 15-0216 (a 2-nitroimidazole derivative)]

Bull Soc Pathol Exot Filiales. 1988;81(3 Pt 2):616-22.
[Article in French]

Abstract

An experiment was carried out on treatment of Trypanosoma brucei brucei experimentally infected sheep with central nervous system involvement with a 2-nitroimidazole derivative: Ro 15-0216 (Hoffmann La Roche & Co Ltd, Basel, Switzerland). After a single intramuscularly or intravenously administration (25 or 50 mg/kg) of this compound in healthy sheep, levels of more than 1 microgram/ml corresponding to trypanocidal concentrations are detected in both blood and cerebrospinal fluid. However, because of short half life, two or three injections a day appeared to be necessary. Six infected sheep were treated by daily intravenous injection for six days: three animals with 25 mg/kg/d and three others with 50 mg/kg/d. Animals which relapsed received 50 mg/kg/d divided in three intravenous injections a day for six days. After a year of observation, all the animals were considered clinically and biologically cured.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetanilides / therapeutic use*
  • Animals
  • Nitroimidazoles / therapeutic use*
  • Sheep
  • Trypanocidal Agents / therapeutic use*
  • Trypanosoma brucei brucei
  • Trypanosomiasis, African / drug therapy*

Substances

  • Acetanilides
  • Nitroimidazoles
  • Trypanocidal Agents
  • Ro 15-0216